Translation-Hub Clinical Translation
The Clinical Translation hub aims to accelerate clinical innovation and optimise the quality of clinical trials. It occupies a unique position among BIH’s Translation Hubs, since it acts as a central catalyst for clinical research and therapy development at BIH and Charité, developing the necessary infrastructure for them to translate innovative ideas into high-quality clinical studies. These infrastructures are extremely complex, ranging from the characterization of patients and their samples through to administration for quality assurance and data collection.
A prominent example of this structural support is the establishment of the Clinical Study Center, jointly supported by BIH and Charité. It acts as a single point of entry for all clinical studies and supports the entire process from study preparation, through to implementation and evaluation. In addition to staff in the classic supporting roles for clinical studies, the hub offers scientifically supervised phenotyping modules to record valuable data, e.g. on the immune, metabolic, mobility and cognitive status of the test subjects. By combining these results with data from the molecular analysis of biosamples, a comprehensive characterization can be carried out.
|Prof. Dr. Stefan Anker||Charité|
|Prof. Dr. Kai-Uwe Eckhardt||Charité|
|PD Dr. Uta Höpken||MDC|
|Prof. Dr. Andreas Meisel, BIH||Charité|
|Prof. Dr. Petra Reinke||Charité|
|Prof. Dr. Birgit Sawitzki||Charité|
|Prof. Dr. Christof von Kalle (ex officio)||BIH|